Direct, Differential Effects of Tamoxifen, 4-Hydroxytamoxifen, and Raloxifene on Cardiac Myocyte Contractility and Calcium Handling
Open Access
- 24 October 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (10), e78768
- https://doi.org/10.1371/journal.pone.0078768
Abstract
Tamoxifen (Tam), a selective estrogen receptor modulator, is in wide clinical use for the treatment and prevention of breast cancer. High Tam doses have been used for treatment of gliomas and cancers with multiple drug resistance, but long QT Syndrome is a side effect. Tam is also used experimentally in mice for inducible gene knockout in numerous tissues, including heart; however, the potential direct effects of Tam on cardiac myocyte mechanical function are not known. The goal of this study was to determine the direct, acute effects of Tam, its active metabolite 4-hydroxytamoxifen (4OHT), and related drug raloxifene (Ral) on isolated rat cardiac myocyte mechanical function and calcium handling. Tam decreased contraction amplitude, slowed relaxation, and decreased Ca2+ transient amplitude. Effects were primarily observed at 5 and 10 μM Tam, which is relevant for high dose Tam treatment in cancer patients as well as Tam-mediated gene excision in mice. Myocytes treated with 4OHT responded similarly to Tam-treated cells with regard to both contractility and calcium handling, suggesting an estrogen-receptor independent mechanism is responsible for the effects. In contrast, Ral increased contraction and Ca2+ transient amplitudes. At 10 μM, all drugs had a time-dependent effect to abolish cellular contraction. In conclusion, Tam, 4OHT, and Ral adversely and differentially alter cardiac myocyte contractility and Ca2+ handling. These findings have important implications for understanding the Tam-induced cardiomyopathy in gene excision studies and may be important for understanding effects on cardiac performance in patients undergoing high-dose Tam therapy.This publication has 44 references indexed in Scilit:
- Noncanonical EF-hand motif strategically delays Ca2+ buffering to enhance cardiac performanceNature Medicine, 2013
- Rapid Changes in Cardiac Myofilament Function following the Acute Activation of Estrogen Receptor-AlphaPLOS ONE, 2012
- Inducible Cre transgenic mouse strain for skeletal muscle-specific gene targetingSkeletal Muscle, 2012
- Cre-loxP DNA recombination is possible with only minimal unspecific transcriptional changes and without cardiomyopathy in Tg(αMHC-MerCreMer) miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Coprescription of Tamoxifen and Medications That Inhibit CYP2D6Journal of Clinical Oncology, 2010
- Cell-Specific Inducible Gene Recombination in Postnatal Inner Ear Supporting Cells and GliaJournal of the Association for Research in Otolaryngology, 2009
- Avoidance of Transient Cardiomyopathy in Cardiomyocyte-Targeted Tamoxifen-Induced MerCreMer Gene Deletion ModelsCirculation Research, 2009
- In Silico Elucidation of the Molecular Mechanism Defining the Adverse Effect of Selective Estrogen Receptor ModulatorsPLoS Computational Biology, 2007
- Altered Ca2+handling by ryanodine receptor and Na+-Ca2+exchange in the heart from ovariectomized rats: role of protein kinase AAmerican Journal of Physiology-Cell Physiology, 2007
- Interaction of hsp90 with steroid receptors: organizing some diverse observations and presenting the newest conceptsMolecular and Cellular Endocrinology, 1990